Rare Ovarian Cancer researchers and consumers work together to produce a research paper.

Congratulations to ALL of the authors, lead author Professor Victoria White from Deakin University, Professor Peter Fuller, Associate Professor Simon Chu, Maria Alexiadia, All from the Hudson Institute of Medical Research, Professor Thomas Jobling from Monash Health, Members from the GCT Survivor Sister Facebook Group our Founder and CEO of ROC Inc Natasha Armour (from Australia), Linda Langdale (from the UK), Sue Rogers, Kaye Ackermann and Kim Eroh (all from the USA), on having your research paper published in the journal Cancer – an international interdisciplinary journal of the American Cancer Society https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.34767 You should ALL feel proud of your […]

Continue reading

The ride COVID couldn’t stop – Ride 4 Research 2022 for Rare Ovarian Cancer Research

Ride 4 Research 2022 (R4R) riders have completed the last leg of the ride on Saturday 18 June 2022. 12 riders lead by R4R organiser Peter Reaburn set out from Canberra on 30 April to cycle 900km in 9 days, however the ride was cut short by two days as there was a COVID outbreak among the riders and support crew. Each of the riders completed the final distance in their own State joined by family and friends A huge congratulation and heartfelt thank you to all the riders, support crew, supporters, major sponsors and to all of you who […]

Continue reading

Auction item: Signed Melbourne Demons 2022 Playing Jersey

Signed Melbourne Demons 2022 playing jersey. Signed by the current 2022 playing group. Also, a signed Certificate of Authenticity from the AFL (Unframed) Item donated by Melbourne Demons FC- All Proceeds go to fundraising for ROC Inc Ride for Research. 5 days left! Lets getting the bidding going all money raised is going to research for Granulosa Cell Tumour (GCT), a rare ovarian cancer research at the Hudson Institute of Medical research. Signed Melbourne Demons 2022 Playing Jersey

Continue reading

Ride 4 Research for rare ovarian cancer research.

12 riders taking on 900 km in 9 days from Canberra to Melbourne, raising vital funds and awareness for rare ovarian cancer. Professor @Peter Reaburn Ride 4 Research organiser and rider for his wife @Claire Reaburn the eldest in Australia diagnosed with Juvenile Granulosa Cell Tumour (JGCT) at 53 years old, @Stephen Mitchell riding for his daughter @Katelyn Mitchell who was diagnosed at 19 years old, Tasha Armour Founder and CEO of ROC Inc, her daughter @Mikayla Armour diagnosed at 16 years old and Dr @Simon Chu world leading researcher for Granulosa Cell Tumours (GCT) from the @Hudson Institute of […]

Continue reading

A step by step rock painting project to inspire you this ANZAC Day

The Poppy Flower is a symbol of remembrance and it is thought that the red of the petals represents the blood of all those who gave their lives. The black represents the mourning of those who didn’t have their loved ones return home. The green represents the grass and crops growing in the future prosperity after the war destroyed so much. ANZAC Day is a day for commemoration, for thanking veterans who served and died in all wars, conflicts and peace keeping operations. To recognise both past and current armed service personnel. Rare Ovarian cancer Inc (ROC Inc) rock painting […]

Continue reading

Friends come together for Ride 4 Research to raise funds for Rare Ovarian Cancer.

Professor Peter Reaburn the event organiser for Ride 4 Research 2022 speaks with fellow riders Mike Dalton and Lee-Ann Dalton about why they are riding. Part of an amazing group of 12 riders that will be taking on 900km in 9 days traveling from Canberra 30 April to Melbourne 8 May finishing on World Ovarian Cancer Day. With 6 days to go the riders have raised over $110,000 towards their goal of $125,000 all money raised going to vital GCT Research at the Hudson Institute of Medical Research in Melbourne. This trio highlight the importance of being aware of the […]

Continue reading